The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. KalVista Pharmaceuticals Inc shares valued at $684,199 were purchased by Venrock Healthcare Capital Par on Feb 07 ’25. At $9.29 per share, Venrock Healthcare Capital Par acquired 73,649 shares. The insider’s holdings grew to 5,086,445 shares worth approximately $47.46 million following the completion of this transaction.
Also, Venrock Healthcare Capital Par purchased 26,703 shares, netting a total of over 245,134 in proceeds. Following the buying of shares at $9.18 each, the insider now holds 5,117,285 shares.
Before that, Venrock Healthcare Capital Par had added 4,137 shares to its account. In a trade valued at $37,812, the 10% Owner bought KalVista Pharmaceuticals Inc shares for $9.14 each. Upon closing the transaction, the insider’s holdings increased to 4,137 shares, worth approximately $47.5 million.
As published in their initiating research note from JMP Securities on January 31, 2025, KalVista Pharmaceuticals Inc [KALV] has been a Mkt outperform and the price target has been revised to $19. Analysts at TD Cowen started covering the stock with ‘”a Buy”‘ outlook in a report released in early January. As of December 18, 2024, BofA Securities has initiated its “Buy” rating for KALV. Earlier on June 15, 2020, H.C. Wainwright initiated its rating. Their recommendation was “a Buy” for KALV stock.
Analyzing KALV Stock Performance
During the last five days, there has been a drop of approximately -5.76%. Over the course of the year, KalVista Pharmaceuticals Inc shares have jumped approximately 10.15%. Shares of the company reached a 52-week high of $10.03 on 02/05/25 and a 52-week low of $7.30 on 01/13/25. A 50-day SMA is recorded $8.86, while a 200-day SMA reached $11.16. Nevertheless, trading volume fell to 0.53 million shares from 0.31 million shares the previous day.
Support And Resistance Levels for KalVista Pharmaceuticals Inc (KALV)
According to the 24-hour chart, there is a support level at 9.07, which, if violated, would cause prices to drop to 8.81. In the upper region, resistance lies at 9.53. The next price resistance is at 9.73. RSI (Relative Strength Index) is 55.83 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.11, which suggests the price will decrease in the coming days. Percent R is at 45.33%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
